nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP3A4—type 2 diabetes mellitus	0.136	1	CbGaD
Cyclophosphamide—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0603	0.0974	CbGbCtD
Cyclophosphamide—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0303	0.049	CbGbCtD
Cyclophosphamide—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0224	0.0362	CbGbCtD
Cyclophosphamide—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0179	0.029	CbGbCtD
Cyclophosphamide—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.017	0.0275	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.017	0.0275	CbGbCtD
Cyclophosphamide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.017	0.0275	CbGbCtD
Cyclophosphamide—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0162	0.0262	CbGbCtD
Cyclophosphamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.016	0.0258	CbGbCtD
Cyclophosphamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0156	0.0253	CbGbCtD
Cyclophosphamide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0152	0.0245	CbGbCtD
Cyclophosphamide—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.015	0.0242	CbGbCtD
Cyclophosphamide—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0144	0.0233	CbGbCtD
Cyclophosphamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0143	0.0231	CbGbCtD
Cyclophosphamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0136	0.022	CbGbCtD
Cyclophosphamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0136	0.022	CbGbCtD
Cyclophosphamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0133	0.0215	CbGbCtD
Cyclophosphamide—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0128	0.0206	CbGbCtD
Cyclophosphamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0125	0.0203	CbGbCtD
Cyclophosphamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0121	0.0196	CbGbCtD
Cyclophosphamide—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0118	0.019	CbGbCtD
Cyclophosphamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0113	0.0183	CbGbCtD
Cyclophosphamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0183	CbGbCtD
Cyclophosphamide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.011	0.0177	CbGbCtD
Cyclophosphamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0104	0.0169	CbGbCtD
Cyclophosphamide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0167	CbGbCtD
Cyclophosphamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0102	0.0165	CbGbCtD
Cyclophosphamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0101	0.0163	CbGbCtD
Cyclophosphamide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00954	0.0154	CbGbCtD
Cyclophosphamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00922	0.0149	CbGbCtD
Cyclophosphamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00909	0.0147	CbGbCtD
Cyclophosphamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00857	0.0138	CbGbCtD
Cyclophosphamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00832	0.0134	CbGbCtD
Cyclophosphamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00821	0.0133	CbGbCtD
Cyclophosphamide—CYP3A5—Losartan—type 2 diabetes mellitus	0.00789	0.0128	CbGbCtD
Cyclophosphamide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00783	0.0127	CbGbCtD
Cyclophosphamide—CYP2C8—Losartan—type 2 diabetes mellitus	0.00759	0.0123	CbGbCtD
Cyclophosphamide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00754	0.0122	CbGbCtD
Cyclophosphamide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00751	0.0121	CbGbCtD
Cyclophosphamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00727	0.0117	CbGbCtD
Cyclophosphamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00696	0.0112	CbGbCtD
Cyclophosphamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00657	0.0106	CbGbCtD
Cyclophosphamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00637	0.0103	CbGbCtD
Cyclophosphamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00579	0.00935	CbGbCtD
Cyclophosphamide—ABCB1—Glyburide—type 2 diabetes mellitus	0.00562	0.00908	CbGbCtD
Cyclophosphamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00529	0.00855	CbGbCtD
Cyclophosphamide—ABCB1—Losartan—type 2 diabetes mellitus	0.00514	0.0083	CbGbCtD
Cyclophosphamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00498	0.00805	CbGbCtD
Cyclophosphamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00478	0.00772	CbGbCtD
Cyclophosphamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00478	0.00772	CbGbCtD
Cyclophosphamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00452	0.0073	CbGbCtD
Cyclophosphamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00337	0.00544	CbGbCtD
Cyclophosphamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00308	0.00497	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP3A4—type 2 diabetes mellitus	0.000553	1	CrCbGaD
Cyclophosphamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000483	CcSEcCtD
Cyclophosphamide—Hepatitis—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000482	CcSEcCtD
Cyclophosphamide—Anaemia—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000481	CcSEcCtD
Cyclophosphamide—Dizziness—Glimepiride—type 2 diabetes mellitus	8.44e-05	0.00048	CcSEcCtD
Cyclophosphamide—Dysgeusia—Losartan—type 2 diabetes mellitus	8.43e-05	0.000479	CcSEcCtD
Cyclophosphamide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	8.42e-05	0.000479	CcSEcCtD
Cyclophosphamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.41e-05	0.000479	CcSEcCtD
Cyclophosphamide—Agitation—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000478	CcSEcCtD
Cyclophosphamide—Hypertension—Metformin—type 2 diabetes mellitus	8.36e-05	0.000476	CcSEcCtD
Cyclophosphamide—Urticaria—Glyburide—type 2 diabetes mellitus	8.36e-05	0.000476	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000472	CcSEcCtD
Cyclophosphamide—Anorexia—Valsartan—type 2 diabetes mellitus	8.28e-05	0.000471	CcSEcCtD
Cyclophosphamide—Muscle spasms—Losartan—type 2 diabetes mellitus	8.27e-05	0.000471	CcSEcCtD
Cyclophosphamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.26e-05	0.00047	CcSEcCtD
Cyclophosphamide—Chest pain—Metformin—type 2 diabetes mellitus	8.25e-05	0.000469	CcSEcCtD
Cyclophosphamide—Myalgia—Metformin—type 2 diabetes mellitus	8.25e-05	0.000469	CcSEcCtD
Cyclophosphamide—Malaise—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000469	CcSEcCtD
Cyclophosphamide—Headache—Pioglitazone—type 2 diabetes mellitus	8.21e-05	0.000467	CcSEcCtD
Cyclophosphamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000466	CcSEcCtD
Cyclophosphamide—Visual impairment—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000465	CcSEcCtD
Cyclophosphamide—Discomfort—Metformin—type 2 diabetes mellitus	8.15e-05	0.000464	CcSEcCtD
Cyclophosphamide—Fatigue—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000464	CcSEcCtD
Cyclophosphamide—Nausea—Glipizide—type 2 diabetes mellitus	8.12e-05	0.000462	CcSEcCtD
Cyclophosphamide—Vomiting—Glimepiride—type 2 diabetes mellitus	8.11e-05	0.000462	CcSEcCtD
Cyclophosphamide—Hypotension—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000462	CcSEcCtD
Cyclophosphamide—Vision blurred—Losartan—type 2 diabetes mellitus	8.11e-05	0.000461	CcSEcCtD
Cyclophosphamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.09e-05	0.00046	CcSEcCtD
Cyclophosphamide—Pain—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.00046	CcSEcCtD
Cyclophosphamide—Constipation—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.00046	CcSEcCtD
Cyclophosphamide—Tremor—Losartan—type 2 diabetes mellitus	8.06e-05	0.000459	CcSEcCtD
Cyclophosphamide—Rash—Glimepiride—type 2 diabetes mellitus	8.05e-05	0.000458	CcSEcCtD
Cyclophosphamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.04e-05	0.000457	CcSEcCtD
Cyclophosphamide—Rash—Sitagliptin—type 2 diabetes mellitus	8.02e-05	0.000456	CcSEcCtD
Cyclophosphamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.01e-05	0.000456	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000456	CcSEcCtD
Cyclophosphamide—Headache—Glimepiride—type 2 diabetes mellitus	7.99e-05	0.000455	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.98e-05	0.000454	CcSEcCtD
Cyclophosphamide—Cough—Irbesartan—type 2 diabetes mellitus	7.98e-05	0.000454	CcSEcCtD
Cyclophosphamide—Headache—Sitagliptin—type 2 diabetes mellitus	7.97e-05	0.000453	CcSEcCtD
Cyclophosphamide—Anaemia—Losartan—type 2 diabetes mellitus	7.95e-05	0.000452	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.91e-05	0.00045	CcSEcCtD
Cyclophosphamide—Agitation—Losartan—type 2 diabetes mellitus	7.91e-05	0.00045	CcSEcCtD
Cyclophosphamide—Oedema—Metformin—type 2 diabetes mellitus	7.91e-05	0.00045	CcSEcCtD
Cyclophosphamide—Tinnitus—Ramipril—type 2 diabetes mellitus	7.9e-05	0.00045	CcSEcCtD
Cyclophosphamide—Hypertension—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000449	CcSEcCtD
Cyclophosphamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.88e-05	0.000448	CcSEcCtD
Cyclophosphamide—Flushing—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000448	CcSEcCtD
Cyclophosphamide—Infection—Metformin—type 2 diabetes mellitus	7.85e-05	0.000447	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000445	CcSEcCtD
Cyclophosphamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000444	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000443	CcSEcCtD
Cyclophosphamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000443	CcSEcCtD
Cyclophosphamide—Chest pain—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000443	CcSEcCtD
Cyclophosphamide—Myalgia—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000443	CcSEcCtD
Cyclophosphamide—Shock—Metformin—type 2 diabetes mellitus	7.78e-05	0.000443	CcSEcCtD
Cyclophosphamide—Malaise—Losartan—type 2 diabetes mellitus	7.76e-05	0.000441	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.75e-05	0.000441	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.74e-05	0.00044	CcSEcCtD
Cyclophosphamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.74e-05	0.00044	CcSEcCtD
Cyclophosphamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.7e-05	0.000438	CcSEcCtD
Cyclophosphamide—Leukopenia—Losartan—type 2 diabetes mellitus	7.7e-05	0.000438	CcSEcCtD
Cyclophosphamide—Discomfort—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000438	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.64e-05	0.000435	CcSEcCtD
Cyclophosphamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.61e-05	0.000433	CcSEcCtD
Cyclophosphamide—Palpitations—Losartan—type 2 diabetes mellitus	7.6e-05	0.000433	CcSEcCtD
Cyclophosphamide—Nausea—Glimepiride—type 2 diabetes mellitus	7.58e-05	0.000431	CcSEcCtD
Cyclophosphamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000431	CcSEcCtD
Cyclophosphamide—Nausea—Sitagliptin—type 2 diabetes mellitus	7.56e-05	0.00043	CcSEcCtD
Cyclophosphamide—Asthenia—Glyburide—type 2 diabetes mellitus	7.55e-05	0.00043	CcSEcCtD
Cyclophosphamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.55e-05	0.000429	CcSEcCtD
Cyclophosphamide—Anorexia—Metformin—type 2 diabetes mellitus	7.54e-05	0.000429	CcSEcCtD
Cyclophosphamide—Cough—Losartan—type 2 diabetes mellitus	7.51e-05	0.000427	CcSEcCtD
Cyclophosphamide—Urticaria—Gliclazide—type 2 diabetes mellitus	7.51e-05	0.000427	CcSEcCtD
Cyclophosphamide—Alopecia—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000426	CcSEcCtD
Cyclophosphamide—Fatigue—Valsartan—type 2 diabetes mellitus	7.49e-05	0.000426	CcSEcCtD
Cyclophosphamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.47e-05	0.000425	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000425	CcSEcCtD
Cyclophosphamide—Oedema—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000425	CcSEcCtD
Cyclophosphamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000424	CcSEcCtD
Cyclophosphamide—Pruritus—Glyburide—type 2 diabetes mellitus	7.45e-05	0.000424	CcSEcCtD
Cyclophosphamide—Constipation—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000422	CcSEcCtD
Cyclophosphamide—Infection—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000422	CcSEcCtD
Cyclophosphamide—Fatigue—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000421	CcSEcCtD
Cyclophosphamide—Hypotension—Metformin—type 2 diabetes mellitus	7.39e-05	0.00042	CcSEcCtD
Cyclophosphamide—Erythema—Ramipril—type 2 diabetes mellitus	7.38e-05	0.00042	CcSEcCtD
Cyclophosphamide—Shock—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000418	CcSEcCtD
Cyclophosphamide—Pain—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000417	CcSEcCtD
Cyclophosphamide—Chest pain—Losartan—type 2 diabetes mellitus	7.32e-05	0.000417	CcSEcCtD
Cyclophosphamide—Arthralgia—Losartan—type 2 diabetes mellitus	7.32e-05	0.000417	CcSEcCtD
Cyclophosphamide—Myalgia—Losartan—type 2 diabetes mellitus	7.32e-05	0.000417	CcSEcCtD
Cyclophosphamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.32e-05	0.000417	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.000416	CcSEcCtD
Cyclophosphamide—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000414	CcSEcCtD
Cyclophosphamide—Rash—Bromocriptine—type 2 diabetes mellitus	7.26e-05	0.000413	CcSEcCtD
Cyclophosphamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.25e-05	0.000413	CcSEcCtD
Cyclophosphamide—Discomfort—Losartan—type 2 diabetes mellitus	7.24e-05	0.000412	CcSEcCtD
Cyclophosphamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000411	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.00041	CcSEcCtD
Cyclophosphamide—Headache—Bromocriptine—type 2 diabetes mellitus	7.21e-05	0.00041	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.2e-05	0.00041	CcSEcCtD
Cyclophosphamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.2e-05	0.00041	CcSEcCtD
Cyclophosphamide—Anorexia—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000405	CcSEcCtD
Cyclophosphamide—Paraesthesia—Metformin—type 2 diabetes mellitus	7.1e-05	0.000404	CcSEcCtD
Cyclophosphamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000404	CcSEcCtD
Cyclophosphamide—Confusional state—Losartan—type 2 diabetes mellitus	7.08e-05	0.000403	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000402	CcSEcCtD
Cyclophosphamide—Dyspnoea—Metformin—type 2 diabetes mellitus	7.05e-05	0.000401	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.02e-05	0.0004	CcSEcCtD
Cyclophosphamide—Oedema—Losartan—type 2 diabetes mellitus	7.02e-05	0.0004	CcSEcCtD
Cyclophosphamide—Infection—Losartan—type 2 diabetes mellitus	6.98e-05	0.000397	CcSEcCtD
Cyclophosphamide—Hypotension—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000397	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000396	CcSEcCtD
Cyclophosphamide—Tremor—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000393	CcSEcCtD
Cyclophosphamide—Shock—Losartan—type 2 diabetes mellitus	6.91e-05	0.000393	CcSEcCtD
Cyclophosphamide—Urticaria—Valsartan—type 2 diabetes mellitus	6.9e-05	0.000392	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.87e-05	0.000391	CcSEcCtD
Cyclophosphamide—Decreased appetite—Metformin—type 2 diabetes mellitus	6.87e-05	0.000391	CcSEcCtD
Cyclophosphamide—Tachycardia—Losartan—type 2 diabetes mellitus	6.85e-05	0.00039	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000389	CcSEcCtD
Cyclophosphamide—Nausea—Bromocriptine—type 2 diabetes mellitus	6.84e-05	0.000389	CcSEcCtD
Cyclophosphamide—Fatigue—Metformin—type 2 diabetes mellitus	6.82e-05	0.000388	CcSEcCtD
Cyclophosphamide—Urticaria—Orlistat—type 2 diabetes mellitus	6.82e-05	0.000388	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000387	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.79e-05	0.000386	CcSEcCtD
Cyclophosphamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.78e-05	0.000386	CcSEcCtD
Cyclophosphamide—Asthenia—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000386	CcSEcCtD
Cyclophosphamide—Agitation—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000386	CcSEcCtD
Cyclophosphamide—Constipation—Metformin—type 2 diabetes mellitus	6.76e-05	0.000385	CcSEcCtD
Cyclophosphamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000381	CcSEcCtD
Cyclophosphamide—Anorexia—Losartan—type 2 diabetes mellitus	6.69e-05	0.000381	CcSEcCtD
Cyclophosphamide—Vomiting—Glyburide—type 2 diabetes mellitus	6.69e-05	0.000381	CcSEcCtD
Cyclophosphamide—Pruritus—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.00038	CcSEcCtD
Cyclophosphamide—Malaise—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000379	CcSEcCtD
Cyclophosphamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.000379	CcSEcCtD
Cyclophosphamide—Rash—Glyburide—type 2 diabetes mellitus	6.64e-05	0.000378	CcSEcCtD
Cyclophosphamide—Dermatitis—Glyburide—type 2 diabetes mellitus	6.63e-05	0.000377	CcSEcCtD
Cyclophosphamide—Leukopenia—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000376	CcSEcCtD
Cyclophosphamide—Headache—Glyburide—type 2 diabetes mellitus	6.59e-05	0.000375	CcSEcCtD
Cyclophosphamide—Hypotension—Losartan—type 2 diabetes mellitus	6.56e-05	0.000373	CcSEcCtD
Cyclophosphamide—Palpitations—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000371	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.52e-05	0.000371	CcSEcCtD
Cyclophosphamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000369	CcSEcCtD
Cyclophosphamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.47e-05	0.000368	CcSEcCtD
Cyclophosphamide—Cough—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000366	CcSEcCtD
Cyclophosphamide—Fatigue—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000366	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.4e-05	0.000364	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.4e-05	0.000364	CcSEcCtD
Cyclophosphamide—Convulsion—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000364	CcSEcCtD
Cyclophosphamide—Pain—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000363	CcSEcCtD
Cyclophosphamide—Constipation—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000363	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.32e-05	0.00036	CcSEcCtD
Cyclophosphamide—Paraesthesia—Losartan—type 2 diabetes mellitus	6.31e-05	0.000359	CcSEcCtD
Cyclophosphamide—Urticaria—Metformin—type 2 diabetes mellitus	6.28e-05	0.000357	CcSEcCtD
Cyclophosphamide—Chest pain—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000357	CcSEcCtD
Cyclophosphamide—Myalgia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000357	CcSEcCtD
Cyclophosphamide—Arthralgia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000357	CcSEcCtD
Cyclophosphamide—Dyspnoea—Losartan—type 2 diabetes mellitus	6.26e-05	0.000356	CcSEcCtD
Cyclophosphamide—Nausea—Glyburide—type 2 diabetes mellitus	6.25e-05	0.000356	CcSEcCtD
Cyclophosphamide—Dizziness—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000356	CcSEcCtD
Cyclophosphamide—Asthenia—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000354	CcSEcCtD
Cyclophosphamide—Discomfort—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000353	CcSEcCtD
Cyclophosphamide—Asthenia—Orlistat—type 2 diabetes mellitus	6.16e-05	0.00035	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.00035	CcSEcCtD
Cyclophosphamide—Pruritus—Valsartan—type 2 diabetes mellitus	6.14e-05	0.00035	CcSEcCtD
Cyclophosphamide—Decreased appetite—Losartan—type 2 diabetes mellitus	6.1e-05	0.000347	CcSEcCtD
Cyclophosphamide—Confusional state—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000345	CcSEcCtD
Cyclophosphamide—Pruritus—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000345	CcSEcCtD
Cyclophosphamide—Fatigue—Losartan—type 2 diabetes mellitus	6.05e-05	0.000344	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000343	CcSEcCtD
Cyclophosphamide—Oedema—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000343	CcSEcCtD
Cyclophosphamide—Vomiting—Gliclazide—type 2 diabetes mellitus	6.01e-05	0.000342	CcSEcCtD
Cyclophosphamide—Pain—Losartan—type 2 diabetes mellitus	6e-05	0.000342	CcSEcCtD
Cyclophosphamide—Constipation—Losartan—type 2 diabetes mellitus	6e-05	0.000342	CcSEcCtD
Cyclophosphamide—Rash—Gliclazide—type 2 diabetes mellitus	5.96e-05	0.000339	CcSEcCtD
Cyclophosphamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.95e-05	0.000339	CcSEcCtD
Cyclophosphamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.94e-05	0.000338	CcSEcCtD
Cyclophosphamide—Urticaria—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000337	CcSEcCtD
Cyclophosphamide—Shock—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000337	CcSEcCtD
Cyclophosphamide—Headache—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000337	CcSEcCtD
Cyclophosphamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000336	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000335	CcSEcCtD
Cyclophosphamide—Tachycardia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000334	CcSEcCtD
Cyclophosphamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.87e-05	0.000334	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000331	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.79e-05	0.000329	CcSEcCtD
Cyclophosphamide—Dizziness—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000327	CcSEcCtD
Cyclophosphamide—Anorexia—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000327	CcSEcCtD
Cyclophosphamide—Dizziness—Orlistat—type 2 diabetes mellitus	5.67e-05	0.000323	CcSEcCtD
Cyclophosphamide—Asthenia—Metformin—type 2 diabetes mellitus	5.67e-05	0.000323	CcSEcCtD
Cyclophosphamide—Hypotension—Ramipril—type 2 diabetes mellitus	5.63e-05	0.00032	CcSEcCtD
Cyclophosphamide—Nausea—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000319	CcSEcCtD
Cyclophosphamide—Pruritus—Metformin—type 2 diabetes mellitus	5.59e-05	0.000318	CcSEcCtD
Cyclophosphamide—Urticaria—Losartan—type 2 diabetes mellitus	5.58e-05	0.000317	CcSEcCtD
Cyclophosphamide—Body temperature increased—Losartan—type 2 diabetes mellitus	5.55e-05	0.000316	CcSEcCtD
Cyclophosphamide—Vomiting—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000314	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000313	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000312	CcSEcCtD
Cyclophosphamide—Rash—Valsartan—type 2 diabetes mellitus	5.47e-05	0.000312	CcSEcCtD
Cyclophosphamide—Dermatitis—Valsartan—type 2 diabetes mellitus	5.47e-05	0.000311	CcSEcCtD
Cyclophosphamide—Vomiting—Orlistat—type 2 diabetes mellitus	5.45e-05	0.00031	CcSEcCtD
Cyclophosphamide—Headache—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000309	CcSEcCtD
Cyclophosphamide—Diarrhoea—Metformin—type 2 diabetes mellitus	5.41e-05	0.000308	CcSEcCtD
Cyclophosphamide—Rash—Orlistat—type 2 diabetes mellitus	5.41e-05	0.000308	CcSEcCtD
Cyclophosphamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000308	CcSEcCtD
Cyclophosphamide—Dermatitis—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000308	CcSEcCtD
Cyclophosphamide—Headache—Orlistat—type 2 diabetes mellitus	5.37e-05	0.000306	CcSEcCtD
Cyclophosphamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000305	CcSEcCtD
Cyclophosphamide—Asthenia—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000305	CcSEcCtD
Cyclophosphamide—Pruritus—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.0003	CcSEcCtD
Cyclophosphamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000298	CcSEcCtD
Cyclophosphamide—Dizziness—Metformin—type 2 diabetes mellitus	5.23e-05	0.000298	CcSEcCtD
Cyclophosphamide—Fatigue—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000295	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.17e-05	0.000294	CcSEcCtD
Cyclophosphamide—Nausea—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000293	CcSEcCtD
Cyclophosphamide—Constipation—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000293	CcSEcCtD
Cyclophosphamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.00029	CcSEcCtD
Cyclophosphamide—Nausea—Orlistat—type 2 diabetes mellitus	5.1e-05	0.00029	CcSEcCtD
Cyclophosphamide—Asthenia—Losartan—type 2 diabetes mellitus	5.04e-05	0.000287	CcSEcCtD
Cyclophosphamide—Vomiting—Metformin—type 2 diabetes mellitus	5.03e-05	0.000286	CcSEcCtD
Cyclophosphamide—Rash—Metformin—type 2 diabetes mellitus	4.99e-05	0.000284	CcSEcCtD
Cyclophosphamide—Dermatitis—Metformin—type 2 diabetes mellitus	4.98e-05	0.000283	CcSEcCtD
Cyclophosphamide—Pruritus—Losartan—type 2 diabetes mellitus	4.97e-05	0.000283	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000282	CcSEcCtD
Cyclophosphamide—Headache—Metformin—type 2 diabetes mellitus	4.95e-05	0.000282	CcSEcCtD
Cyclophosphamide—Dizziness—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000281	CcSEcCtD
Cyclophosphamide—Diarrhoea—Losartan—type 2 diabetes mellitus	4.8e-05	0.000273	CcSEcCtD
Cyclophosphamide—Urticaria—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000272	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000271	CcSEcCtD
Cyclophosphamide—Vomiting—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.00027	CcSEcCtD
Cyclophosphamide—Rash—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000268	CcSEcCtD
Cyclophosphamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000267	CcSEcCtD
Cyclophosphamide—Nausea—Metformin—type 2 diabetes mellitus	4.7e-05	0.000267	CcSEcCtD
Cyclophosphamide—Headache—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000266	CcSEcCtD
Cyclophosphamide—Dizziness—Losartan—type 2 diabetes mellitus	4.64e-05	0.000264	CcSEcCtD
Cyclophosphamide—Vomiting—Losartan—type 2 diabetes mellitus	4.46e-05	0.000254	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000252	CcSEcCtD
Cyclophosphamide—Nausea—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000252	CcSEcCtD
Cyclophosphamide—Rash—Losartan—type 2 diabetes mellitus	4.43e-05	0.000252	CcSEcCtD
Cyclophosphamide—Dermatitis—Losartan—type 2 diabetes mellitus	4.42e-05	0.000252	CcSEcCtD
Cyclophosphamide—Headache—Losartan—type 2 diabetes mellitus	4.4e-05	0.00025	CcSEcCtD
Cyclophosphamide—Asthenia—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000246	CcSEcCtD
Cyclophosphamide—Pruritus—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000242	CcSEcCtD
Cyclophosphamide—Nausea—Losartan—type 2 diabetes mellitus	4.17e-05	0.000237	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000234	CcSEcCtD
Cyclophosphamide—Dizziness—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000227	CcSEcCtD
Cyclophosphamide—Vomiting—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000218	CcSEcCtD
Cyclophosphamide—Rash—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000216	CcSEcCtD
Cyclophosphamide—Dermatitis—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000216	CcSEcCtD
Cyclophosphamide—Headache—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000215	CcSEcCtD
Cyclophosphamide—Nausea—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000204	CcSEcCtD
Cyclophosphamide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.99e-06	7.3e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.98e-06	7.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.96e-06	7.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.95e-06	7.23e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.93e-06	7.2e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.93e-06	7.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.92e-06	7.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.92e-06	7.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.91e-06	7.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.9e-06	7.16e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.9e-06	7.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.89e-06	7.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.88e-06	7.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.88e-06	7.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.87e-06	7.11e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.85e-06	7.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.84e-06	7.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.84e-06	7.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.81e-06	7.03e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.81e-06	7.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.79e-06	7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.78e-06	6.98e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.72e-06	6.9e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.72e-06	6.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.72e-06	6.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.71e-06	6.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.71e-06	6.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.71e-06	6.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.71e-06	6.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.7e-06	6.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.67e-06	6.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.67e-06	6.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.67e-06	6.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.66e-06	6.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.65e-06	6.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.64e-06	6.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.64e-06	6.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.61e-06	6.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.6e-06	6.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.6e-06	6.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.59e-06	6.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	4.55e-06	6.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.53e-06	6.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.53e-06	6.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.52e-06	6.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.49e-06	6.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.47e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.46e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	4.46e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.46e-06	6.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.45e-06	6.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.45e-06	6.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.44e-06	6.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.42e-06	6.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	6.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	6.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.34e-06	6.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.34e-06	6.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.3e-06	6.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.27e-06	6.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.27e-06	6.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.26e-06	6.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.23e-06	6.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.21e-06	6.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.2e-06	6.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.2e-06	6.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.17e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.17e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.17e-06	6.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.16e-06	6.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.15e-06	6.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.15e-06	6.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.13e-06	6.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.12e-06	6.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.1e-06	5.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	4.09e-06	5.97e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.07e-06	5.95e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.07e-06	5.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.07e-06	5.95e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.05e-06	5.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.04e-06	5.91e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4e-06	5.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.99e-06	5.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.98e-06	5.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.92e-06	5.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.91e-06	5.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.91e-06	5.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.9e-06	5.7e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.88e-06	5.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.87e-06	5.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.84e-06	5.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.84e-06	5.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.84e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.84e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.83e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.82e-06	5.58e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-06	5.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-06	5.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.8e-06	5.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	5.53e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.78e-06	5.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.77e-06	5.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.77e-06	5.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.76e-06	5.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.74e-06	5.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.74e-06	5.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.74e-06	5.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	5.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.72e-06	5.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.72e-06	5.43e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.71e-06	5.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.71e-06	5.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.67e-06	5.36e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.66e-06	5.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.65e-06	5.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.64e-06	5.32e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.63e-06	5.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	5.3e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.62e-06	5.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.61e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.61e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.6e-06	5.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.59e-06	5.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.58e-06	5.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.58e-06	5.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.57e-06	5.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.56e-06	5.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.56e-06	5.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	5.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.53e-06	5.15e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.52e-06	5.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.52e-06	5.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.49e-06	5.1e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.48e-06	5.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	5.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.42e-06	5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.42e-06	5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.41e-06	4.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	4.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	4.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.36e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.36e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.36e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.36e-06	4.9e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.34e-06	4.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.32e-06	4.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.3e-06	4.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.3e-06	4.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	4.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.28e-06	4.79e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.27e-06	4.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.27e-06	4.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	4.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.25e-06	4.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.23e-06	4.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.2e-06	4.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.2e-06	4.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.18e-06	4.65e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.17e-06	4.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.16e-06	4.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.16e-06	4.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.15e-06	4.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.15e-06	4.59e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.12e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.11e-06	4.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.11e-06	4.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.09e-06	4.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.09e-06	4.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.09e-06	4.51e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.07e-06	4.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.07e-06	4.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	4.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	4.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.04e-06	4.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.04e-06	4.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.99e-06	4.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	4.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	2.95e-06	4.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.94e-06	4.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.93e-06	4.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	4.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.91e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.91e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	4.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.89e-06	4.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.89e-06	4.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	4.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.82e-06	4.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.79e-06	4.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.77e-06	4.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.72e-06	3.97e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.71e-06	3.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.67e-06	3.9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.67e-06	3.9e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.65e-06	3.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-06	3.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	3.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.51e-06	3.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.51e-06	3.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.5e-06	3.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.5e-06	3.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	3.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	3.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.46e-06	3.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	3.57e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.43e-06	3.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.39e-06	3.49e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	3.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	3.48e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.33e-06	3.4e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.33e-06	3.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.33e-06	3.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.29e-06	3.35e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.28e-06	3.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	3.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.24e-06	3.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.23e-06	3.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	3.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	3.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	3.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	3.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	3.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.17e-06	3.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.14e-06	3.13e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.13e-06	3.11e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	3e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.02e-06	2.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	2.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	2.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.96e-06	2.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.95e-06	2.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.92e-06	2.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.91e-06	2.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.89e-06	2.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.8e-06	2.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	2.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	2.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	2.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-06	2.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.43e-06	2.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.43e-06	2.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	2.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	1.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.6e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	1.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.59e-07	9.63e-06	CbGpPWpGaD
